| Literature DB >> 22561053 |
Mohammad Titi1, Andrew Overhiser1, Ozlem Ulusarac1, Gary W Falk2, Amitabh Chak3, Kenneth Wang4, Prateek Sharma5.
Abstract
Patients with Barrett's esophagus are frequently treated with radiofrequency ablation (RFA). Those that undergo this procedure have a low risk of developing subsquamous intestinal metaplasia, and none have been reported to develop subsquamous dysplasia or cancer. We report the development of subsquamous neoplasia in 3 patients who were treated with RFA for Barrett's esophagus (2 developed adenocarcinoma and 1 developed high-grade dysplasia). The identification of these cases indicates the need for continued surveillance following RFA, even after complete eradication of intestinal metaplasia, and caution for widespread use of ablation, especially in patients with low-risk Barrett's esophagus.Entities:
Mesh:
Year: 2012 PMID: 22561053 PMCID: PMC5511030 DOI: 10.1053/j.gastro.2012.04.051
Source DB: PubMed Journal: Gastroenterology ISSN: 0016-5085 Impact factor: 22.682